The U.S. CDC Advisory Committee on Immunization Practices (ACIP) on Friday urged for the pause on the Johnson & Johnson vaccine to be lifted and for administration to resume. It will be available to everyone ages 18 years and older.
“Lifting the pause is in the best public interest of the United States,” a participant in the advisory committee meeting said. Side effects of the vaccine will continue to be monitored and the CDC will continue to distribute information on the safety of the vaccine.
Subscribe Gain access to all our Premium contents.
More than 100+ articles.